Skip to main content
. 2021 Aug 5;11(8):e049515. doi: 10.1136/bmjopen-2021-049515

Table 1.

Eligibility criteria

Inclusion criteria Exclusion criteria
  • Hospitalised patients with AECOPD*

  • Fever, axillary temperature ≥38°C

  • ≥40 years of age

  • Pneumonia identified by X-ray or CT of the chest

  • Able to understand and communicate to ensure the completion of the trial

  • Severe respiratory failure requiring admittance to ICU

  • Concurrent infection at another site (eg, urinary tract infection)

  • Voluntary participation and provide written informed consent

  • Immunosuppression secondary to chemotherapy, AIDS or malignant tumour of blood system

  • Comorbidities requiring corticosteroids (at least prednisone 30 mg/day or equivalent for more than 30 days)

  • Invasive mechanical ventilation

  • Patients with malignant tumours receiving chemotherapy or radiotherapy

  • Pregnancy

  • Participation in another clinical trial

  • Previously enrolment into the study

  • Refuse to attend

*The diagnostic criteria for AECOPD are based on the recommendation in Global Initiative for Chronic Obstructive Pulmonary Disease guideline.4

AECOPD, acute exacerbation of chronic obstructive pulmonary disease; AIDS, acquired immunodeficiency syndrome; CT, computer tomography; ICU, intensive care unit.